All these assumptions of pump and dumps and expecting the worst from a CR are clearly a reflection of the companies they've invested in, and what they've done with raised funds.
While the potential dilution is not ideal, they clearly forget or are simply blind to the progress this company has made. We're investing in potential here, there's no ignorance to these facts, and the company has made strides - just look at the announcements from the last CR and what we've achieved since then.I'm happy to continue to be an investor as long as the company makes progress that I'm happy with. Looking forward to seeing what the announcement details are - having any bigger players enter the game would only be a bonus.
- Forums
- ASX - By Stock
- PWN
- Ann: Trading Halt
Ann: Trading Halt, page-7
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add PWN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.20M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $2.258K | 188.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2762841 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 0.011 |
13 | 4434212 | 0.010 |
9 | 3812394 | 0.009 |
9 | 2391000 | 0.008 |
10 | 5468548 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2762841 | 3 |
0.013 | 2912087 | 5 |
0.014 | 307441 | 3 |
0.015 | 2075892 | 6 |
0.016 | 2758482 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
PWN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online